Blood test for nerve damage in multiple sclerosis and stroke
Part of Brain & nervous system, Heart & circulation, Immune system & allergy clinical trials.
This study looks at tiny particles in the blood that may show how much nerve damage has happened. It aims to find a simple blood test to help doctors understand and monitor conditions like multiple sclerosis and stroke.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 50 years old and have been diagnosed with relapsing-remitting multiple sclerosis (MS).
- You have not taken steroids for MS in the past 3 months and are not taking them now.
- You have not had any previous disease-modifying treatments for MS.
- You do not have any other neurological or autoimmune disease.
- You are over 18 and have had an ischemic stroke within the last 24 hours.
- You do not have signs of infection on admission and have no history of immune, blood, or previous neurological disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study measures blood markers (from a serum blood sample) to see how nerve and brain changes relate to MS disease activity and disability over time. It may help researchers better monitor MS, especially in people followed in the OFSEP program.
This study looks for signs of “synapse damage” in multiple sclerosis using blood tests and brain imaging (MRI). The goal is to find biomarkers that may help better understand MS and how it changes over time.
This study looks at blood “auto-antibodies,” which are immune proteins that may attack the body, in people with certain brain and nerve conditions. It may help researchers better understand these diseases and how the immune system is involved.
This study looks at whether blood tests taken after your first stroke can help predict if you might have memory or thinking problems early on. It focuses on people with a stroke in the basal ganglia area of the brain, with the goal of identifying those who may need extra support sooner.
This study looks at a blood marker called TWEAK to see if it can signal when multiple sclerosis or its first symptoms might flare up again. If you join, your blood would be checked at regular visits to help predict future inflammation.
This study looks at tiny particles in your blood called extracellular vesicles to see if they can help predict how well you will recover after a stroke or brain injury. If you are starting rehabilitation soon after your stroke, you may be able to join.
Hear when a new Multiple sclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.